The microbiota in inflammatory bowel disease: current and therapeutic insights
Erin R Lane,1 Timothy L Zisman,2 David L Suskind1 1Division of Gastroenterology and Hepatology, Seattle Children’s Hospital, 2Division of Gastroenterology, University of Washington, Seattle, WA, USA Abstract: Inflammatory bowel disease is a heterogeneous group of chronic disorders that res...
Guardado en:
Autores principales: | Lane ER, Zisman TL, Suskind DL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/08ffeb74be7a4c2f898158b410953c3a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Gianluca Ianiro, et al.
Publicado: (2021) -
Fecal microbiota transplant – a new frontier in inflammatory bowel disease
por: Sunkara T, et al.
Publicado: (2018) -
Fecal calprotectin and microbiota of the gut
por: V. G. Gorokhova, et al.
Publicado: (2016) -
Metalloproteinases in Inflammatory Bowel Diseases
por: Marônek M, et al.
Publicado: (2021) -
Cathelicidin – A Novel Potential Marker of Pediatric Inflammatory Bowel Disease
por: Krawiec P, et al.
Publicado: (2021)